Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Manage Online Access
    • Individual Subscriptions
    • Institutional Subscriptions
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcast
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Manage Online Access
    • Individual Subscriptions
    • Institutional Subscriptions
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcast
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Reviews/Commentaries/ADA Statements

2010 Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement

  1. Ragnar Hanas, MD, PHD1,
  2. Garry John, FRCPATH2 and
  3. On behalf of the International HbA1c Consensus Committee*
  1. 1Department of Pediatrics, Uddevalla Hospital, Uddevalla, Sweden;
  2. 2Department of Laboratory Medicine, Norfolk and Norwich University Hospital Norwich, Norfolk, U.K.
  1. Corresponding author: Ragnar Hanas, ragnar.hanas{at}vgregion.se.
Diabetes Care 2010 Aug; 33(8): 1903-1904. https://doi.org/10.2337/dc10-0953
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

Glycated hemoglobin concentrations (most commonly hemoglobin A1C; HbA1c) reflect time-averaged blood glucose during the previous 2–3 months and are used as the gold standard for long-term follow-up of glycemic control. Standardization with common calibration was first proposed in 1984 (1). It was only after the publication of the Diabetes Control and Complications Trial (DCCT) study in 1993 (2), however, that the issue of international standardization of HbA1c measurements became an important objective for scientists and clinicians. At that time, the lack of international standardization resulted in several countries developing National standardization programs; most notable of these are:

  • in the U.S., the National Glycohemoglobin Standardization Program (NGSP), with the DCCT HPLC method used as the primary reference method;

  • in Sweden, with the Mono S ion exchange chromatography designated as the comparison method;

  • in Japan, with use of common calibrators (six calibrators available for use) with HbA1c values assigned by the Japan Diabetes Society.

A common feature of these national programs is the absence of primary and secondary reference materials. To overcome this lack of reference materials, achieve global standardization, and meet the requirements of the European Union directive on in vitro diagnostic (IVD) medical devices, the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) established a Working Group on HbA1c Standardization to develop a reference measurement system within the concept of metrological traceability. Such a system has been developed consisting of incubation with the enzyme endoproteinase Glu-C, cleavage of the NH2-terminal hexapeptide of the β-chain, and separation and quantification of glycated and nonglycated hexapeptides by mass spectrometry or capillary electrophoresis (3). The analyte measured is a hemoglobin molecule having a stable adduct of glucose to the NH2-terminal valine of the hemoglobin β-chain (βN-1-deoxyfructosyl-hemoglobin). Pure HbA1c and pure HbA0 are isolated from human blood and mixed in well-defined proportions to produce a certified primary reference material set used to calibrate the primary reference measurement system (PRMS). The PRMS values are assigned to secondary reference materials (SRMs; whole blood), and the SRMs are used by the manufacturers to calibrate their instruments. A laboratory network has been established to implement and maintain the PRMS (4).

Adopting the new IFCC standardization procedure will result in HbA1c percentage values being lowered due to the higher specificity on the reference method. It has been suggested that lowering the percentage value of the HbA1c reported may lead to poorer glycemic control in some patients (5), and IFCC has recommended the use of SI (Système International) units of mmol/mol, which would minimize the risk of confusion between IFCC percentage units and DCCT/NGSP percentage units (6).

Expressing HbA1c as an average glucose concentration has been widely discussed, as there is a convincing linear relationship between HbA1c and average glucose concentration in both adults (7) and children (8). Nevertheless, not all population groups have been evaluated adequately.

Clinicians and scientists have unanimously welcomed the use of the IFCC reference method for calibration purposes, and the implementation of this standardization process is ongoing. There has been a considerable debate, however, regarding the number issue, i.e., whether HbA1c should be expressed in percentage units related to the DCCT study or mmol/mol related to the IFCC method. There is an evident need to keep doctors, nurses, and people with diabetes educated to ensure a worldwide understanding of previously reported and upcoming scientific HbA1c results. A first consensus meeting was held in 2007 (9–10), where it was decided that the new IFCC reference system for HbA1c represents the only valid anchor to implement standardization of the measurement, and that HbA1c results were to be reported worldwide in IFCC units (mmol/mol) and derived NGSP units (%), using the IFCC-NGSP master equation.

A second consensus meeting was held at the International Diabetes Federation (IDF) meeting in Montreal on 21 October 2009. The American Diabetes Association (ADA), the European Association for the Study of Diabetes (EASD), the IDF, the IFCC, and the International Society for Pediatric and Adolescent Diabetes (ISPAD) were represented at that meeting, as well as some editors from medical journals, and the following statements were approved by these organizations:

  1. HbA1c test results should be standardized worldwide, including the reference system and results reporting.

  2. The IFCC reference system for HbA1c represents the only valid anchor to implement standardization of the measurement.

  3. HbA1c results are to be reported by clinical laboratories worldwide in SI (Système International) units (mmol/mol, no decimals) and derived NGSP units (%, one decimal), using the IFCC-NGSP master equation (DCCT units).

  4. HbA1c conversion tables including both SI (IFCC) and NGSP/DCCT units should be easily accessible to the diabetes community.

  5. Editors of journals and other printed material are strongly recommended to require that submitted manuscripts report HbA1c in both SI (IFCC) and NGSP/DCCT units.

  6. The reportable term for glycated hemoglobin is HbA1c, although other abbreviations may be used in guidelines and educational material (A1C).

  7. The above consensus recommendations apply through 2011, when they will be discussed again at the next consensus meeting at the IDF meeting in Dubai, December 2011.

HbA1c-derived average glucose values (ADAGs) calculated from the HbA1c results were not included in the consensus due to the above-mentioned limitations of this procedure. However, the use of an estimated average glucose (eAG) (7) in discussion with an individual patient may add to the consultation process, and the availability of such estimation may be advantageous. Agreement should be reached at a local level on how to make this estimation available.

In a world of increased communication, and with the ever-increasing availability of information that both lay people and professionals may access via the Internet, it is inevitable that scientific results from studies such as the DCCT will be brought to the attention of interested individuals for decades to come. By reporting in both IFCC and DCCT units, ongoing continuity between these reporting systems will be ensured. The submission of manuscripts containing both units will facilitate the alignment of the various HbA1c methods, as the master equation will be used in the laboratory instruments for calculating the DCCT units, i.e., both the IFCC units and the DCCT units will have the same basis. It is therefore of vital importance that all laboratories and other users of instruments for measuring HbA1c, either in the laboratory or at the point of care, take part in quality control and quality assessment programs to ensure accurate results (individual countries will vary in the way this is performed). We hope that the recommendation of dual reporting in submitted manuscripts will be adopted promptly by all scientific journals publishing diabetes articles.

Acknowledgments

No potential conflicts of interest relevant to this article were reported.

APPENDIX

International HbA1c Consensus Committee members

For ADA: David Kendall, Sue Kirkman, Sue McLaughlin, Richard Bergenstal, David Sacks, and David Nathan. For EASD: Viktor Joergens and Ulf Smith. For IDF: Jean-Claude Mbanya, Massimo Massi Benedetti, Marg McGill, and Larry Deeb. For IFCC: Garry John and Graham Beastall. For ISPAD: Ragnar Hanas and Thomas Danne.

Footnotes

  • ↵*A complete list of the members of the International HbA1c Consensus Committee can be found in the appendix.

  • This article is being simultaneously published in 2010 in Annals of Clinical Biochemistry, Clinical Chemistry, Clinical Chemistry and Laboratory Medicine, Diabetes Care, Diabetes Research and Clinical Practice, Diabetologia, Diabetic Medicine, and Pediatric Diabetes.

    • © 2010 by the American Diabetes Association, the European Association for the Study of Diabetes, the International Diabetes Federation, the International Federation of Clinical Chemistry and Laboratory Medicine, and the International Society for Pediatric and Adolescent Diabetes.

    Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

    References

    1. ↵
      1. Peterson CM,
      2. Jovanovic L,
      3. Raskin P,
      4. Goldstein DE
      : A comparative evaluation of glycosylated haemoglobin assays: feasibility of references and standards. Diabetologia 1984;26:214–217
      OpenUrlPubMedWeb of Science
    2. ↵
      The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977–986
      OpenUrlCrossRefPubMedWeb of Science
    3. ↵
      1. Hoelzel W,
      2. Weykamp C,
      3. Jeppsson JO,
      4. Miedema K,
      5. Barr JR,
      6. Goodall I,
      7. Hoshino T,
      8. John WG,
      9. Kobold U,
      10. Little R,
      11. Mosca A,
      12. Mauri P,
      13. Paroni R,
      14. Susanto F,
      15. Takei I,
      16. Thienpont L,
      17. Umemoto M,
      18. Wiedmeyer HM
      : IFCC Working Group on HbA1c Standardization. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004;50:166–174
      OpenUrlAbstract/FREE Full Text
    4. ↵
      1. Weykamp C,
      2. John WG,
      3. Mosca A,
      4. Hoshino T,
      5. Little R,
      6. Jeppsson JO,
      7. Goodall I,
      8. Miedema K,
      9. Myers G,
      10. Reinauer H,
      11. Sacks DB,
      12. Slingerland R,
      13. Siebelder C
      : The IFCC Reference Measurement System for HbA1c: a 6-year progress report. Clin Chem 2008;54:240–248
      OpenUrlAbstract/FREE Full Text
    5. ↵
      1. Hanas R
      : Psychological impact of changing the scale of reported HbA(1c) results affects metabolic control. Diabetes Care 2002;25:2110–2111
      OpenUrlFREE Full Text
    6. ↵
      1. Nordin G,
      2. Dybkaer R
      International Federation Of Clinical Chemistry And Laboratory Medicine, IFCC Scientific Division Nordin G, Dybkaer R : Recommendation for term and measurement unit for “HbA1c”. Clin Chem Lab Med 2007;45:1081–1082
      OpenUrlCrossRefPubMedWeb of Science
    7. ↵
      1. Nathan DM,
      2. Kuenen J,
      3. Borg R,
      4. Zheng H,
      5. Schoenfeld D,
      6. Heine RJ
      : A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473–1478
      OpenUrlAbstract/FREE Full Text
    8. ↵
      Diabetes Research in Children Network (DirecNet) Study Group. Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors. Diabetes Care 2008;31:381–385
      OpenUrlAbstract/FREE Full Text
    9. ↵
      American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, International Diabetes Federation. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care 2007;30:2399–2400
      OpenUrlFREE Full Text
    10. ↵
      American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, International Diabetes Federation. Consensus statement on the worldwide standardisation of the HbA1c measurement. Diabetologia 2007;50:2042–2043
      OpenUrlCrossRefPubMedWeb of Science
    View Abstract
    PreviousNext
    Back to top
    Diabetes Care: 33 (8)

    In this Issue

    August 2010, 33(8)
    • Table of Contents
    • About the Cover
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Diabetes Care.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    2010 Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement
    (Your Name) has forwarded a page to you from Diabetes Care
    (Your Name) thought you would like to see this page from the Diabetes Care web site.
    Citation Tools
    2010 Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement
    Ragnar Hanas, Garry John, On behalf of the International HbA1c Consensus Committee
    Diabetes Care Aug 2010, 33 (8) 1903-1904; DOI: 10.2337/dc10-0953

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    2010 Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement
    Ragnar Hanas, Garry John, On behalf of the International HbA1c Consensus Committee
    Diabetes Care Aug 2010, 33 (8) 1903-1904; DOI: 10.2337/dc10-0953
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Acknowledgments
      • APPENDIX
      • Footnotes
      • References
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    Reviews/Commentaries/ADA Statements

    • Metabolic Syndrome and Risk of Cancer
    • Emerging Applications of Metabolomic and Genomic Profiling in Diabetic Clinical Medicine
    • Diabetes and Risk of Parkinson’s Disease
    Show more Reviews/Commentaries/ADA Statements

    Consensus Statement

    • How Do We Define Cure of Diabetes?
    • American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
    Show more Consensus Statement

    Similar Articles

    Navigate

    • Current Issue
    • Standards of Care Guidelines
    • Online Ahead of Print
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • BMJ Open - Diabetes Research & Care
    • Standards of Medical Care in Diabetes
    • Scientific Sessions Abstracts
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2019 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.